Trials / Completed
CompletedNCT03021551
Oxygen Reserve Index: Utility as Early Warning for Desaturation in Morbidly Obese Patients
- Status
- Completed
- Phase
- —
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Masimo Corporation · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Oxygen Reserve Index (ORi) is a reference that could help clinicians with their assessments of normoxic and hyperoxic states by scaling the measured absorption information between 0.00 and 1.00. An ORi of 0.00 corresponds to partial pressure of oxygen (PaO2) values of 100 mmHg and below and an ORi of 1.00 corresponds to PaO2 values of 200 mmHg and above. This is clinical study designed to evaluate the clinical utility of the Oxygen Reserve Index (ORI) as an early warning for arterial hemoglobin desaturation during the induction of general anesthesia and tracheal intubation in obese patients undergoing elective surgical procedures.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rainbow sensor | Masimo Radical-7 and Root System with ORi parameter in all subjects are enrolled in the test group and receive an Rainbow sensor during their elective surgery. |
Timeline
- Start date
- 2016-09-15
- Primary completion
- 2018-07-20
- Completion
- 2018-07-20
- First posted
- 2017-01-16
- Last updated
- 2022-04-19
- Results posted
- 2022-04-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03021551. Inclusion in this directory is not an endorsement.